Candriam Equities L Biotech.I-H EUR Acc/ LU1006082199 /
| NAV13/05/2024 | Diferencia+15.9500 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
|---|---|---|---|---|
| 2,027.4399EUR | +0.79% | reinvestment | Equity Worldwide | Candriam ▶ |
Rendimiento mensual
| ene. | feb. | mar. | abr. | may. | jun. | jul. | ago. | sep. | oct. | nov. | dic. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | -23.24 | -4.43 | 3.75 | 3.78 | 5.33 | -8.43 | 12.46 | -2.53 | 3.75 | -12.49 | 8.75 | -2.94 | -19.97% |
| 2017 | 5.35 | 6.80 | -0.20 | 1.09 | -3.22 | 9.15 | 2.42 | 6.37 | 0.68 | -6.52 | 0.12 | 1.45 | +24.87% |
| 2018 | 6.60 | -4.86 | -2.17 | -3.34 | 4.39 | 0.63 | 4.29 | 3.92 | -2.21 | -14.22 | 3.85 | -8.55 | -13.02% |
| 2019 | 12.85 | 3.33 | -0.81 | -5.08 | -4.94 | 9.21 | -2.52 | -2.51 | -4.38 | 10.29 | 11.72 | 2.21 | +30.43% |
| 2020 | -5.35 | -1.19 | -5.42 | 12.40 | 9.51 | 1.27 | -2.96 | 0.83 | 0.64 | -2.75 | 9.44 | 2.92 | +18.93% |
| 2021 | 1.81 | -2.57 | -4.35 | 2.71 | -2.27 | 6.35 | -1.45 | 3.89 | -4.27 | 0.17 | -4.38 | 2.32 | -2.71% |
| 2022 | -10.88 | -1.96 | 5.39 | -7.76 | -3.50 | 2.63 | 4.48 | 0.83 | -2.35 | 6.56 | 5.77 | -3.11 | -5.50% |
| 2023 | 2.75 | -5.94 | 0.32 | 2.02 | -1.38 | 1.02 | -0.32 | -0.34 | -4.46 | -6.26 | 5.71 | 13.23 | +4.95% |
| 2024 | 1.22 | 1.20 | -0.07 | -6.27 | 3.88 | - | - | - | - | - | - | - | - |
Valores estimados
| Año hasta la fecha | 6 Meses | Promedio móvil | 3 Años | 5 Años | |
|---|---|---|---|---|---|
| Volatilidad | 16.18% | 17.40% | 16.29% | 20.07% | 22.72% |
| Índice de Sharpe | -0.29 | 2.12 | -0.06 | -0.16 | 0.15 |
| El mes mejor | +13.23% | +13.23% | +13.23% | +13.23% | +13.23% |
| El mes peor | -6.27% | -6.27% | -6.27% | -10.88% | -10.88% |
| Pérdida máxima | -11.21% | -11.21% | -15.74% | -30.29% | -32.04% |
| Rendimiento superior | +1.76% | - | +1.73% | -5.87% | +3.46% |
Todas las cotizaciones en EUR
Tramos
| Nombre | Tipo de beneficio | Prec. de rescate | Promedio móvil | 3 Años | |
|---|---|---|---|---|---|
| Candriam Equities L Biotechnolog... | reinvestment | 2,022.5400 | +5.01% | +9.69% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 216.5200 | +4.70% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,027.4399 | +2.77% | +2.08% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,183.8799 | +5.54% | +22.83% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,379.4600 | +4.51% | +21.37% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 354.4400 | +4.63% | +25.16% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 319.4000 | +5.67% | +25.33% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 197.5100 | +0.43% | +0.45% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,809.4800 | +5.33% | +12.43% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 146.7200 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 588.5300 | +3.78% | +7.52% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,534.3799 | +4.91% | +9.30% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 193.8100 | +1.99% | +1.59% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 202.0700 | +2.87% | +4.10% | |
| Candriam Equities L Biotech.R US... | reinvestment | 262.2900 | +5.07% | +11.59% | |
| Candriam Equities L Biotechnolo... | reinvestment | 826.0500 | +4.16% | +8.88% | |
| Candriam Equities L Biotechnolog... | paying dividend | 754.4300 | +4.13% | +8.78% |
Performance
| Año hasta la fecha | -0.33% | ||
|---|---|---|---|
| 6 Meses | +18.47% | ||
| Promedio móvil | +2.77% | ||
| 3 Años | +2.08% | ||
| 5 Años | +41.92% | ||
| 10 Años | - | ||
| Desde el principio | +35.16% | ||
| Año | |||
| 2023 | +4.95% | ||
| 2022 | -5.50% | ||
| 2021 | -2.71% | ||
| 2020 | +18.93% | ||
| 2019 | +30.43% | ||
| 2018 | -13.02% | ||
| 2017 | +24.87% | ||
| 2016 | -19.97% | ||
